Nadia Rosencher

Rivaroxaban versus Enoxaparin for Thromboprophylaxis after Total Knee Arthroplasty

Michael R. Lassen, Walter Ageno, Lars C. Borris et al. · New England Journal of Medicine · 2008 · 1.3K citations · Full text

Medicine, Pharmacotherapy, Surgery +17

Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial

Bengt I. Eriksson, Ola E. Dahl, Nadia Rosencher et al. · The Lancet · 2007 · 1.1K citations

Medicine, Orthopedic Surgery, Pharmacotherapy +15

Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE‐MODEL randomized trial

Bengt I. Eriksson, O.E. Dahl, Nadia Rosencher et al. · Journal of Thrombosis and Haemostasis · 2007 · 984 citations · Full text

Medicine, Orthopaedic Surgery, Orthopedic Surgery +15

Orthopedic Surgery Transfusion Hemoglobin European Overview (OSTHEO) study: blood management in elective knee and hip arthroplasty in Europe*

Nadia Rosencher, H. E. M. Kerkkamp, G. Macheras et al. · Transfusion · 2003 · 614 citations

Medicine, Orthopaedic Surgery, Orthopedic Surgery +17

A new oral direct thrombin inhibitor, dabigatran etexilate, compared with enoxaparin for prevention of thromboembolic events following total hip or knee replacement: the BISTRO II randomized trial

Bengt I. Eriksson, O.E. Dahl, Harry R. Büller et al. · Journal of Thrombosis and Haemostasis · 2004 · 413 citations

Medicine, Orthopaedic Surgery, Orthopedic Surgery +17